Product
imipenem/cilastatin
1 clinical trial
2 indications
Indication
Complicated UTIIndication
PyelonephritisClinical trial
A Phase 3, Multi-Center, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in the Treatment of Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis, in AdultsStatus: Recruiting, Estimated PCD: 2024-08-01